Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04068753
Title Niraparib in Combination With TSR-042 in Patients With Recurrent or Progressive Cervix Cancer (STAR)
Acronym STAR
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.